LY9 Antikörper (N-Term) (FITC)
Kurzübersicht für LY9 Antikörper (N-Term) (FITC) (ABIN8006828)
Target
Alle LY9 (CD229) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Anti-CD229/LY9 Antibody FITC Conjugated
-
Spezifität
- No cross reactivity with other proteins.
-
Kreuzreaktivität (Details)
- No cross-reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified.
-
Immunogen
- A synthetic peptide corresponding to a sequence at the N-terminus of human CD229/LY9, which shares 55.9% and 61.8% amino acid (aa) sequence identity with mouse and rat CD229/LY9, respectively.
-
Isotyp
- IgG
-
-
anti-Lymphocyte Antigen 9 (CD229) (AA 384-642) antibody
CD229 Reaktivität: Maus WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphocyte Antigen 9 (CD229) (N-Term) antibodyCD229 Reaktivität: Human, Maus, Ratte IHC, FACS, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphocyte Antigen 9 (CD229) antibodyCD229 Reaktivität: Human WB, FACS, IP, ICC, Func Wirt: Maus Monoclonal HLy9-25 unconjugated
anti-Lymphocyte Antigen 9 (CD229) (AA 160-360) antibodyCD229 Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphocyte Antigen 9 (CD229) antibody (APC)CD229 Reaktivität: Human FACS Wirt: Maus Monoclonal HLy9-25 APC
anti-Lymphocyte Antigen 9 (CD229) antibody (PE)CD229 Reaktivität: Human FACS Wirt: Maus Monoclonal HLy9-25 PE
anti-Lymphocyte Antigen 9 (CD229) antibodyCD229 Reaktivität: Human WB, FACS, IP, ICC Wirt: Maus Monoclonal HLy9-25 unconjugated
anti-Lymphocyte Antigen 9 (CD229) (AA 156-253) antibodyCD229 Reaktivität: Human WB, ELISA Wirt: Maus Polyclonal unconjugated
anti-Lymphocyte Antigen 9 (CD229) (AA 384-642) antibodyCD229 Reaktivität: Maus WB, IHC, IP, ICC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Lymphocyte Antigen 9 (CD229) (AA 301-400) antibodyCD229 Reaktivität: Human ELISA, ICC, IF (p), IF (cc), IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Haltbarkeit
- 12 months
-
-
- LY9 (CD229) (Lymphocyte Antigen 9 (CD229))
-
Andere Bezeichnung
- LY9
-
Hintergrund
-
Background: T-lymphocyte surface antigen Ly-9 is a protein that in humans is encoded by the LY9 gene. This gene is mapped to 17q21.31. LY9 has also recently been designated CD229 (cluster of differentiation 229). LY9 belongs to the SLAM family of immunomodulatory receptors and interacts with the adaptor molecule SAP.
Gene Full Name: lymphocyte antigen 9
-
Gen-ID
- 4063
-
UniProt
- Q9HBG7
-
Pathways
- BCR Signaling
Target
-
